Two new battery-operated digital reflectance meters for blood glucose measurement have been tested for precision and accuracy in a laboratory trial. Reflocheckf (Boehringer Company Ltd) is calibrated from a bar code printed on each test strip, Refloluxf (Boehringer Company Ltd) from a bar code on acetate film provided with each bottle of BM-Test-Glycemie 20-800R strips, which can also be read visually. Three aqueous standards (3·3, 8·3 and 11·7 mrnol/l) were assayed 10 times on each of 10 days. Overall coefficients of variation for Reflocheck were 2,8,1·7 and 2·0% and for Reflolux 3·1, 1·5 and 2·8% respectively. One hundred and four blood samples measured on the machines gave very high correlations with a manual hexokinase assay: for Reflocheck, y = 1· Ix -0·7, r = 0·99 and for Reflolux, y =1·07x + 0·1, r = 0·99. In the range 2·2-10 mmol, errors of 1 mmol or more occurred on seven occasions with Reflocheck and eight with Reflolux (n = 80) but none of these errors was of therapeutic significance. The performance of both machines was as good or better than previously published data for similar instruments. The ease of calibration and accuracy of both machines are advantageous as is the use of BM-Test-Glycemie 20-800R by Reflolux which enables a check to be made on visual readings.
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Small reflectance meters which measure blood glucose from the colours developed on reagent strips are widely used in the homes of diabetic patients, in hospital wards and in casualty departments. Laboratory evaluation of meters has usually shown them to be sufficiently accurate for therapeutic purposes even if they have not always had sufficient precision for diagnostic decision-making.l" Quality control of equipment used in these settings by unsupervised non-technical staff has proved difficult and, in particular, calibration of the instruments has not always been satisfactory. Machines presently available are generally internally calibrated at one or two points on the curve from unused reagent strips and a standard solution or coloured acetate blocks. Some machines do not make allowance for batch-tobatch variations in the reagent strips.
This report is an evaluation of two new reflectance meters, one designed primarily for hospital ward use and the other for patients at home. Both incorporate a new method of automatic external calibration.
Materials and methods
Reflocheck (Boehringer Company Ltd) is a small battery-operated digital reflectance meter which measures blood glucose concentration from a new reagent strip (Reflocheck Glucose") over the range 1·1-25 mmol/l, The bar code printed on the back of each strip is read as it is inserted into the machine and provides the information required to calculate the calibration curve. As the machine is switched on, internal programming checks take place and the built-in timer is activated as a drop of blood is placed on the reagent pad. After 1 minute a buzzer sounds, the strip is wiped with cotton wool and inserted through the bar code reader into the machine. Acceptance of the strip is acknowledged by the machine which automatically calculates and displays-the result at the end of the second minute.
Similarly, Reflolux is a small batteryoperated digital meter designed to read BM-Test-Glycemie 20-800R reagent strips and has been designed primarily for patient use. A bar code film containing calibration data for the batch is enclosed in each tin of strips. This is loaded into a slot on the hinged flap of the instrument prior to use. Timing is again initiated by a button and the display window shows elapsed seconds; a bell at 60 seconds indicates the strip should be wiped and another bell at 120 seconds indicates that the hinged flap holding the strip should be closed to allow immediate digital display of the result. On each of 10 consecutive days 10 assays with each of three control solutions were performed on each machine to obtain within-day and between-day variation. The control solutions contained 3·3, 8·3 and 11·7 mrnol/l glucose.
One hundred and four blood samples were drawn from diabetic patients or subjects undergoing insulin-tolerance tests and a glucose concentration was measured on both machines. A 100 JLl sample was immediately deproteinated in 1 ml of 0·33 rnmol/l perchloric acid, stored at 4 cC for up to 7 days and assayed in a Glucoquantf hexokinase assay (Boehringer Company Ltd). This assay was controlled with Precisetf standard glucose solutions and Pre-cinorm SI!!l and Precipath S~serum standards. Intra-assay coefficients of variation for aqueous standards and normal serum were all less than 1% and 2·4% for pathological serum standard (Precipath S).
Inter-assay coefficients of variation for aqueous and serum standards are shown in Table 1 .
Results

PRECISION
The mean, standard deviation and coefficient of variation of the 10 tests on each day with each of the standard glucose solutions for Reflolux and Reflocheck are shown in Table 2 . Reflolux consistently over-estimated the concentrations of all three standard solutions but standard deviations and coefficients of variation were low (maximal within-day variation 4·1 %). The performance of Reflocheck was more accurate and slightly more precise with these aqueous solutions of glucose (Table 2) . Data from all 10 days has been used to derive between-day Between-day analysis
coefficients of variation which are shown at the bottom of Table 2 .
ACCUR.ACY
Comparisons of Reflolux and Reflocheck with the hexokinase reference method are shown by linear regression in the panels of Figure 1 .
There was a very high degree of correlation for the 104 samples on both the Reflolux (y = 1·07x + 0·1; r = 0·99) and Reflocheck (y = I·Ix -0·7; r = 0,99). The solid lines on Figure 1 are the lines of identity. It can be seen that neither machine produced any results which would give rise to a serious clinical error; however, 5% of results with Reflolux were more than 10% below the reference method and 22% were higher. With Reflocheck 13% of results were more than 10% below the reference method and 15% more than 10% above. Most of these larger errors occurred at the extremes of the range of sensitivity of the instruments. Reflocheck, for example, under-estimated only three values and over-estimated four values by more than 1 mmol/l over the range 2·2-10 mmol (n = 80). For Reflolux there were seven values underestimated and one value over-estimated by more than 1 mmol over the same range. None of the errors were of therapeutic significance.
Discussion
The ideal blood glucose meter for clinical side-room use should be simple to operate and designed to encourage correct technique, which includes accurate timing. It should also provide consistently accurate results over a wide range of blood glucose concentrations and be independent of external calibration errors. The Reflocheck fulfils these requirements. It has a built-in display of elapsed time and rejects strips which have been left too long before insertion into the instrument. It is automatically calibrated to the code printed on every test strip and gives accuracy and precision at least as good as any previously published data for other instruments over a slightly wider useful range of blood glucose concentrations. Precision was not significantly different from the manual reference method. There have been no machine failures in the test period and each battery has a life of over 200 tests. A mains adapter is available. Although not the subject of the present report, we have subsequently found the machine to-be as accurate and robust when used routinely on the ward by a variety of nursing staff.
Reflolux is also accurate and precise enough for day-to-day use by diabetic patients at home. The particular advantage of the instrument is that it uses the standard BM-Test-Glycemie 2D-SOOR strips, allowing the patient to make visual measurements of blood glucose without having to keep two sets of strips. The stability of the colours developed by the reagents permits the patient to check results on the meter several hours after making a visual reading"? and enables visually-read strips to be checked by meter in the clinic, a valuable educational aid. The simplicity and increased precision of the automatic calibration system is a further useful refinement. However, battery life is rather short at approximately 75 tests.
Both of these machines offer accuracy and precision at least as good as many currently available systems for rapid blood glucose measurement. These results are achieved with a simpler technique of calibration than is available with most other instruments. They represent useful further refinements to the technique of bedside and home blood glucose monitoring.
